Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 17, 2019 - Issue 12
Submit an article Journal homepage
18,685
Views
38
CrossRef citations to date
0
Altmetric
Review

Features of Marfan syndrome not listed in the Ghent nosology – the dark side of the disease

Yskert von Kodolitscha German Aorta Center Hamburg at University Hospital Hamburg Eppendorf University Heart Centre, Clinics for Cardiology and Heart Surgery, VASCERN HTAD European Reference CentreCorrespondence[email protected]
View further author information
,
Anthony Demolderb Center for Medical Genetics and Department of Cardiology, Ghent University Hospital, VASCERN HTAD European Reference Centre, Ghent, BelgiumView further author information
,
Evaldas Girdauskasa German Aorta Center Hamburg at University Hospital Hamburg Eppendorf University Heart Centre, Clinics for Cardiology and Heart Surgery, VASCERN HTAD European Reference CentreView further author information
,
Harald Kaemmererc Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich of the Free State of Bavaria, MunichView further author information
,
Katharina Kornhuberc Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Centre Munich of the Free State of Bavaria, MunichView further author information
,
Laura Muino Mosquerad Department of Pediatric Cardiology and Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumView further author information
,
Shaine Morrise Department of Pediatrics-Cardiology, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX, USAView further author information
,
Enid Neptunef Division of Pulmonary and Critical Care Medicine and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information
,
Reed Pyeritzg Departments of Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USAView further author information
,
Svend Rand-Hendriksenh TRS, National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Nesoddtangen, NorwayView further author information
,
Alexander Rahmani Department of Conservative Dentistry, Periodontology and Preventive Dentistry, Hannover Medical School, HannoverView further author information
,
Nina Riiseh TRS, National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Nesoddtangen, NorwayView further author information
,
Leema Robertj Department of Clinical Genetics, Guy’s and St Thomas’ NHS Foundation Trust, London, UKView further author information
,
Ingmar Staufenbieli Department of Conservative Dentistry, Periodontology and Preventive Dentistry, Hannover Medical School, HannoverView further author information
,
Katalin Szöcsa German Aorta Center Hamburg at University Hospital Hamburg Eppendorf University Heart Centre, Clinics for Cardiology and Heart Surgery, VASCERN HTAD European Reference CentreView further author information
,
Thy Thy Vanemh TRS, National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Nesoddtangen, Norway;k Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, NorwayView further author information
,
Stephan J. Linkel Clinic of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;m Ophthalmological practice at the University Clinic Hamburg-Eppendorf, zentrumsehstärke, Hamburg, GermanyView further author information
,
Marina Voglern German Marfan Association, Marfan Hilfe Deutschland e.V, Eutin, GermanyView further author information
,
Anji Yetmano Vascular Medicine, Children’s Hospital and Medical Center, Omaha, USAView further author information
&
Julie De Backerb Center for Medical Genetics and Department of Cardiology, Ghent University Hospital, VASCERN HTAD European Reference Centre, Ghent, BelgiumView further author information
 show all
Pages 883-915 | Received 09 Sep 2019, Accepted 11 Dec 2019, Published online: 08 Jan 2020

References

  • Marfan AB-J. Un cas de déformation congènital des quatre membres plus pronouncée aux extrémitiés charactérisée par l’allongement des os avec un certain degré d’amonassesment. Bull Mem Soc Med Hop (Paris) Ser. 1896;3(13):220–226.
  • Marfan AB-J. La dolichoste´nome´lie (dolichome´lie arachnodactylie). Ann Med. 1938;44:5–29.
  • Piper RK, Irvine-Jones E. Arachnodactylia and its association with congenital heart disease: report of a case and review of the literature. Am J Dis Children. 1926;31(6):832–839.
  • Börger F. Über zwei Fälle von Arachnodaktylie. Z Kinder-Heilk. 1914;12(2–3):161–184.
  • von Pfaundler M. Arachnodaktylie. Münchener Medizinische Wochenschrift. 1914;61(5):280.
  • Weve H. Über Arachnodakylie (Dystrophia mesodermalis congenita, Typus Marfan). Arch Augenheilkd. 1931;104:1–46.
  • Jéquier PM. Observations sur le syndrome de Marfan (dolichosténomelié ou arachnodactylie). Helv Med Acta. 1943;10:233–236.
  • Etter LE, Glover LP. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of the aorta. JAMA. 1943;123:88–89.
  • von Kodolitsch Y, De Backer J, Schüler H et al. Perspectives on the revised ghent criteria for the diagnosis of Marfan syndrome. The Application of Clinical Genetics;2015. [cited 2015 Jun 8], 137–155.
  • Mckusick VA. The cardiovascular aspects of Marfan’s syndrome: a heritable disorder of connective tissue. Circulation. 1955;11(3):321–342.
  • Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103:2499–2509.
  • Dietz HC, Cutting CR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–339.
  • Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22:5–55.
  • Das Marfan-Syndrom. ed. (Deutschland), MH). Berlin, Heidelberg: Springer Berlin Heidelberg; 2017.
  • Marfan Hilfe (Deutschland) e.V. Das Marfan-Syndrom. Berlin, Heidelberg: Springer. 2017; Available from: https://link.springer.com/book/10.1007/978-3-662-53259-1
  • Loeys BL, Dietz HC, Braverman AC, et al. The revised ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–485.
  • Beroukhim RS, Roosevelt G, Yetman AT. Comparison of the pattern of aortic dilation in children with the Marfan’s syndrome versus children with a bicuspid aortic valve. Am J Cardiol. 2006;98(8):1094–1095.
  • Detaint D, Michelena HI, Nkomo VT, et al. Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy. Heart. 2014;100(2):126–134.
  • Mueller GC, Stark V, Steiner K, et al. Impact of age and gender on cardiac pathology in children and adolescents with Marfan syndrome. Pediatr Cardiol. 2013;34(4):991–998.
  • Wozniak-Mielczarek L, Sabiniewicz R, Drezek-Nojowicz M, et al. Differences in cardiovascular manifestation of Marfan syndrome between children and adults. Pediatr Cardiol. 2019;40(2):393–403.
  • Itagaki S, Chikwe JP, Chiang YP, et al. Long-term risk for aortic complications after aortic valve replacement in patients with bicuspid aortic valve versus Marfan syndrome. J Am Coll Cardiol. 2015;65(22):2363–2369.
  • Nistri S, Porciani MC, Attanasio M, et al. Association of Marfan syndrome and bicuspid aortic valve: frequency and outcome. Int J Cardiol. 2012;155(2):324–325.
  • Milleron O, Ropers J, Arnoult F, et al. Clinical significance of aortic root modification associated with bicuspid aortic valve in Marfan Syndrome. Circ Cardiovasc Imaging. 2019;12(3):e008129.
  • Ellis PR, Cooley DA, De Bakey ME. Clinical considerations and surgical treatment of annulo-aortic ectasia. report of successful operation. J Thorac Cardiovasc Surg. 1961;42:363–370.
  • Golden RL, Lakin H. The forme fruste in Marfan’s syndrome. N Engl J Med. 1959;260(16):797–801.
  • Pepe G, Nistri S, Giusti B, et al. Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. BMC Med Genet. 2014;15:23.
  • Girdauskas E, Geist L, Disha K, et al. Genetic abnormalities in bicuspid aortic valve root phenotype: preliminary results. Eur J Cardiothorac Surg. 2017;52(1):156–162.
  • Beighton P, De Paepe A, Danks D, et al. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet A. 1988;29(3):581–594.
  • De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62(4):417–426.
  • Phornphutkul C, Rosenthal A, Nadas AS. Cardiac manifestations of Marfan syndrome in infancy and childhood. Circulation. 1973;47(3):587–596.
  • Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome. clinical and echocardiographic study of prevalence and natural history. Am J Med. 1983;74(5):797–807.
  • Sisk HE, Zahka KG, Pyeritz RE. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol. 1983;52(3):353–358.
  • Chen S, Fagan LF, Nouri S, et al. Ventricular dysrhythmias in children with Marfan’s syndrome. Am J Dis Child. 1985;139(3):273–276.
  • Geva T, Sanders SP, Diogenes MS, et al. Two-dimensional and doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol. 1990;65(18):1230–1237.
  • Morse RP, Rockenmacher S, Pyeritz RE, et al. Diagnosis and management of infantile marfan syndrome. Pediatrics. 1990;86(6):888–895.
  • Brown OR, DeMots H, Kloster FE, et al. Aortic root dilatation and mitral valve prolapse in Marfan’s syndrome: an echocardiographic study. Circulation. 1975;52(4):651–657.
  • Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J. 1982;104(1):115–135.
  • Pini R, Roman MJ, Kramer-Fox R, et al. Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. comparison to primary mitral valve prolapse and normal subjects. Circulation. 1989;80(4):915–924.
  • Rybczynski M, Mir TS, Sheikhzadeh S, et al. Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol. 2010;106(7):1048–1053.
  • Rybczynski M, Treede H, Sheikhzadeh S, et al. Predictors of outcome of mitral valve prolapse in patients with the marfan syndrome. Am J Cardiol. 2011;107(2):268–274.
  • Kühne K, Keyser B, Groene EF, et al. FBN1 gene mutation characteristics and clinical features for the prediction of mitral valve disease progression. Int J Cardiol. 2013;168(2):953–959.
  • Aydin A, Adsay BA, Sheikhzadeh S, et al. Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One. 2013;8(12):e81281.
  • Rybczynski M, Bernhardt AM, Rehder U, et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A. 2008;146A(24):3157–3166.
  • Sheikhzadeh S, De Backer J, Gorgan N, et al. The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome. Orphanet J Rare Dis. 2014;9(1):203.
  • Stark VC, Huemmer M, Olfe J, et al. The pulmonary artery in pediatric patients with Marfan syndrome: an underestimated aspect of the disease. Pediatr Cardiol. 2018;39(6):1194–1199.
  • Nollen GJ, van Schijndel KE, Timmermans J, et al. Magnetic resonance imaging of the main pulmonary artery: reliable assessment of dimensions in Marfan patients on a simple axial spin echo image. Int J Cardiovasc Imaging. 2003;19(2):141–147. discussion 149-150.
  • Espinola-Zavaleta N, Iqbal FM, Nanda NC, et al. Echocardiographic study of a Mestizo-Mexican population with Marfan syndrome. Echocardiography. 2010;27(8):923–930.
  • Joyce F, Tingleff J, Pettersson G. Expanding indications for the Ross operation. J Heart Valve Dis. 1995;4(4):352–363.
  • Sievers HH, Hanke T, Stierle U, et al. A critical reappraisal of the ross operation: renaissance of the subcoronary implantation technique? Circulation. 2006;114(1 Suppl):I504–511.
  • Gu X, He Y, Li Z, et al. Echocardiographic versus histologic findings in Marfan syndrome. Tex Heart Inst J. 2015;42(1):30–34.
  • Alpendurada F, Wong J, Kiotsekoglou A, et al. Evidence for Marfan cardiomyopathy. Eur J Heart Fail. 2010;12(10):1085–1091.
  • Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999;340:1307–1313.
  • Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132(22):2118–2125.
  • Hetzer R, Siegel G, Delmo Walter EM. Cardiomyopathy in Marfan syndrome. Eur J Cardiothorac Surg. 2016;49(2):561–567.
  • Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol. 2003;41:329–332.
  • Alpendurada F, Wong J, Kiotsekoglou A, et al. Evidence for Marfan cardiomyopathy. Eur J Heart Fail. 2010;12:1085–1091.
  • Savolainen A, Nisula L, Keto P, et al. Left ventricular function in children with the marfan syndrome. Eur Heart J. 1994;15(5):625–630.
  • Das BB, Taylor AL, Yetman AT. Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome. Pediatr Cardiol. 2006;27:256–258.
  • De Backer JF, Devos D, Segers P, et al. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol. 2006;112(3):353–358.
  • Rybczynski M, Koschyk DH, Aydin MA, et al. Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol. 2007;30:19–24.
  • Kiotsekoglou A, Sutherland GR, Moggridge JC, et al. Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome. Eur J Echocardiography. 2009;2:295–302.
  • Meijboom LJ, Timmermans J, Van Tintelen JP, et al. Evaluation of left ventricular dimensions and function in Marfan’s syndrome without significant valvular regurgitation. Am J Cardiol. 2005;95(6):795–797.
  • Rouf R, MacFarlane EG, Takimoto E, et al. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. JCI Insight. 2017;2(15):e91588.
  • Cook JR, Carta L, Bénard L, et al. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Investig. 2014;124(3):1329–1339.
  • Steijns F, van Hengel J, Sips P, et al. A heart for fibrillin: spatial arrangement in adult wild-type murine myocardial tissue. Histochem Cell Biol. 2018;150(3):271–280.
  • Humphrey JD, Schwartz MA, Tellides G, et al. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ Res. 2015;116(8):1448–1461.
  • Aalberts JJJ, van Tintelen JP, Meijboom LJ, et al. Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome. Gene. 2014;534:40–43.
  • Chen C, Fagan LF, Nouri S, et al. Ventricular dysrhythmias in children with Marfan’s Syndrome. Am J Dis Children. 1985;139(3):273–276.
  • Aydin A, Adsay BA, Sheikhzadeh S, et al. Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS ONE. 2013;8:e81281.
  • Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J Am Med Assoc. 2001;285(18):2370–2375.
  • Rowland D, Mace J. Coincidence of Wolff-Parkinson-White and Marfan syndromes. J Pediatr. 1975;86(3):482.
  • Johnson CD. The Wolff-Parkinson-White syndrome associated with Marfan’s syndrome. Bol Asoc Med P R. 1989;81:361-364.
  • Savolainen A, Kupari M, Toivonen L, et al. Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med. 1997;241:225–230.
  • Hoffmann BA, Rybczynski M, Rostock T, et al. Prospective risk stratification of sudden cardiac death in Marfan’s syndrome. Int J Cardiol. 2013;167:2539–2545.
  • Cameron DE, Alejo DE, Patel ND, et al. Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years. Ann Thorac Surg. 2009;87:1344–1350.
  • Bear ES, Tung MY, Bordiuk J. Marfan’s syndrome with complete heart block and junctional rhythm. JAMA. 1971;217:335.
  • Chopra KL, Krishnan S, Joseph PP. Intermittent bundle branch block and complete heart block in Marfan’s syndrome. Indian Heart J. 1970;22:53–56.
  • Arunamata AA, Nguyen CT, Ceresnak SR, et al. Utility of serial 12-lead electrocardiograms in children with Marfan syndrome. Cardiol Young. 2018;28(8):1009–1013.
  • Becker AE, van Mantgem JP. The coronary arteries in Marfan’s syndrome. A morphologic study. Am J Cardiol. 1975;36:315–321.
  • Mortensen KH, Thuesen L, Kristensen IB, et al. Spontaneous coronary artery dissection: A western Denmark heart registry study. Catheterization Cardiovasc Interventions. 2009;74(5):710–717.
  • Vanzetto G, Berger-Coz E, Barone-Rochette G, et al. Prevalence, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection: results from a database of 11,605 patients. Eur J Cardiothorac Surg. 2009;35:250–254.
  • Henkin S, Negrotto SM, Tweet MS, et al. Spontaneous coronary artery dissection and its association with heritable connective tissue disorders. Heart. 2016;102:876–881.
  • Vandamme M, De Backer J, De Backer T, et al. The spectrum of spontaneous coronary artery dissection: illustrated review of the literature. Acta Cardiol. 2017;72:599–609. (Ed.^(Eds).
  • Krittanawong C, Kumar A, Johnson KW, et al. Conditions and factors associated with spontaneous coronary artery dissection (from a national population-based cohort study). Am J Cardiol. 2019;123:249–253.
  • Palank EA, Dawson JT, Cowen GD, et al. Primary dissecting aneurysm of the right coronary artery. Chest. 1977;72:774–776.
  • Corrado D, Thiene G, Cocco P, et al. Non-atherosclerotic coronary artery disease and sudden death in the young. Heart. 1992;68(6):601–607.
  • Bateman AC, Gallagher PJ, Vincenti AC. Sudden death from coronary artery dissection. J Clin Pathol. 1995;48:781–784.
  • Bonacchi M, Prifti E, Giunti G, et al. Emergency management of spontaneous coronary artery dissection. J Cardiovasc Surg. 2002;43(2):189–193.
  • Angiolillo DJ, Moreno R, Macaya C. Isolated distal coronary dissection in Marfan syndrome. Ital Heart J Suppl. 2004;5:305–306.
  • Wain-Hobson J, Roule V, Dahdouh Z, et al. Spontaneous coronary artery dissection: one entity with several therapeutic options. Cardiovasc Revascularization Med. 2012;13(3):203.e201–204.
  • Tokura M, Taguchi I, Kageyama M, et al. Clinical features of spontaneous coronary artery dissection. J Cardiol. 2014;63(2):119–122.
  • Sao C, Wakabayashi K, Suzuki H. Natural course of isolated spontaneous coronary artery dissection in Marfan syndrome. Int J Cardiol. 2014;177:20–22.
  • Kaadan MI, MacDonald C, Ponzini F, et al. Prospective cardiovascular genetics evaluation in spontaneous coronary artery dissection. Circ Genom Precis Med. 2018;11(4):e001933.
  • Lovitt WVJ, Corzine WJJ. Dissecting intramural hemorrhage of anterior descending branch of left coronary artery. AMA Arch Pathol. 1952;54:458–462.
  • Boschetti AE, Levine A. Cystic medionecrosis with dissecting aneurysm of coronary arteries. AMA Arch Intern Med. 1958;141(5):428.
  • Duarte SBCP, Beraldo DO, Cesar LAM, et al. anomalous coronary artery origin in a young patient with Marfan syndrome. Case Rep Cardiol. 2017;3861923:5.
  • Zanotti G, Gupta R, Reece TB, et al. Aortic valve sparing root replacement with unroofing and reconstruction of an anomalous right coronary artery. Ann Thorac Surg. 2016;101(5):1980–1982.
  • Brothers JA, Harris MA, Paridon SM. Anomalous aortic origin of a coronary artery in siblings with Marfan syndrome. Cardiol Young. 2011;21:238–240.
  • Papadopoulos DP, Moyssakis I, Votteas VE. Coexistence of anomalous origin of the coronary arteries and severe aortic regurgitation in Marfan syndrome. Clin Rheumatol. 2006;25:737–738.
  • Imperadore F, Girardini D, Vassanelli C, et al. Dissection of the ascending aorta complicated by acute myocardial infarction in a patient with Marfan’s syndrome and anomalous origin of the left circumflex artery. description of a case. G Ital Cardiol. 1994;24(4):435–440.
  • Menon VK, Alurkar VM, Durairaj M. Anomalous origin of the coronary artery in Marfan’s syndrome. Indian Heart J. 1983;35:176–177.
  • Winter MM, Koolbergen DR, Groenink M, et al. Computed tomography coronary angiography should be performed in all patients with Marfan Syndrome prior to aortic root replacement. Int J Cardiol. 2014;177(2):e70–71.
  • Jegatheeswaran A, Devlin PJ, McCrindle BW, et al. Features associated with myocardial ischemia in anomalous aortic origin of a coronary artery: a congenital heart surgeons’ society study. J Thorac Cardiovasc Surg. 2019;158(3):822–834.e823.
  • Yetman AT, McCrindle BW. The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol. 2010;26:e137-e139.
  • Szeberin Z, Fehérvári M, Krepuska M, et al. Fetuin-A serum levels in patients with aortic aneurysms of Marfan syndrome and atherosclerosis. Eur J Clin Invest. 2011;41(2):176–182.
  • Van Herck JL, De Meyer GRY, Martinet W, et al. Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice. Circulation. 2009;120(24):2478–2487.
  • Van der Donckt C, Van Herck JL, Schrijvers DM, et al. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur Heart J. 2015;36(17):1049–1058.
  • Shah H, Jan MU, Altaf A, et al. Correlation of hyper-homocysteinemia with coronary artery disease in absence of conventional risk factors among young adults. J Saudi Heart Assoc. 2018;30(4):305–310.
  • Benke K, Ágg B, Mátyás G, et al. Gene polymorphisms as risk factors for predicting the cardiovascular manifestations in Marfan syndrome: role of folic acid metabolism enzyme gene polymorphisms in Marfan syndrome. Thromb Haemost. 2015;114(4):748–756.
  • Giustia B, Porciania MC, Brunelli T, et al. Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J. 2003;24(22):2038–2045.
  • Wilson DG, Bellamy MF, Ramsey MW, et al. Endothelial function in Marfan syndrome: selective impairment of flow- mediated vasodilation. Circulation. 1999;99:909–915.
  • Kang SS, Rosenson RS. Analytic approaches for the treatment of hyperhomocysteinemia and Its Impact on vascular disease. Cardiovasc Drugs Ther. 2018;32:233–240. (Ed.^(Eds).
  • Yang HHC, van Breemen C, Chung AWY. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. Vascul Pharmacol. 2010;52(1–2):37–45.
  • Angeloni E, Vitaterna A, Pirelli M, et al. Effects of statin therapy on ascending aorta aneurysms growth: a propensity-matched analysis. Int J Cardiol. 2015;191:52–55.
  • McLoughlin D, McGuinness J, Byrne J, et al. Pravastatin reduces marfan aortic dilation. Circulation. 2011;124(11Suppl):S168–173.
  • Boucker P, Li WP, Matz RL, et al. LRP1 functions as an atheroprotective integrator of TGFβ and PDGF signals in the vascular wall: implications for Marfan syndrome. PLoS ONE. 2007;2(5):e448.
  • Morris SA, Orbach DB, Geva T, et al. Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders. Circulation. 2011;124:388–396.
  • Croisile B, Deruty R, Pialat J, et al. Aneurysm of the internal carotid artery and cervical mega-dolicho-arteries in Marfan syndrome. Neurochirurgie. 1988;34:342-347.
  • Kasirajan K, Matteson B, Marek JM, et al. Covered stents for true subclavian aneurysms in patients with degenerative connective tissue disorders. J Endovascular Ther. 2004;10:647-652.
  • Kono AK, Higashi M, Morisaki H, et al. High prevalence of vertebral artery tortuosity of Loeys-Dietz syndrome in comparison with Marfan syndrome. Jpn J Radiol. 2010;28:273–277.
  • Mariucci EM, Lovato L, Rosati M, et al. Dilation of peripheral vessels in Marfan syndrome: importance of thoracoabdominal MR angiography. Int J Cardiol. 2013;167:2928–2931.
  • Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37:275–281.
  • Franken R, El Morabit A, De Waard V, et al. Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome. Int J Cardiol. 2015;194:7–12.
  • Celestin B, Jondeau G, Milleron O. Increased vertebral arterial tortuosity index in adult marfan FBN1 associated with adverses outcomes. Arch Cardiovasc Dis Suppl. 2018;10(2):254.
  • Schoenhoff FS, Yildiz M, Langhammer B, et al. The fate of nonaortic arterial segments in Marfan patients. J Thorac Cardiovasc Surg. 2019;157:2150–2156.
  • Yetman AT, Roosevelt GE, Veit N, et al. Distal aortic and peripheral arterial aneurysms in patients with Marfan syndrome. J Am Coll Cardiol. 2011;58(24):2544–2545.
  • Groner LK, Lau C, Devereux RB, et al. Imaging of the postsurgical aorta in Marfan syndrome. Curr Treat Options Cardiovasc Med. 2018;20(10):80.
  • Latter DA, Ricci MA, Forbes RDC, et al. Internal carotid artery aneurysm and Marfan’s syndrome. Canadian Journal of Surgery. 1989;6:463-466.
  • Aschwanden M, Wegmann W. Dissecting aneurysm of the common iliac artery in Marfan syndrome: rupture following sports activities. Schweizerische Medizinische Wochenschrift. 1990;120(22):836–839.
  • Aghoutane N, Bakkali T, Zoulati M, et al. Un anévrisme de l’artère axillo-sous-clavière en pré-rupture révélant un syndrome de Marfan. J Med Vasc. 2018;44(1):71–75.
  • Flanagan PV, Geoghegan J, Egan TJ. Iliac artery aneurysm in Marfan’s Syndrome. Eur J Vasc Surg. 1990;4(3):323–324.
  • Mounier-Vehier C, Millaire A, Vrtovsnik F, et al. Dissecting aneurysm of the left iliac artery disclosing Marfan’s disease. Annales De Cardiologie Et D’angeiologie. 1991;40:537–540.
  • Hatrick AG, Malcolm PN, Burnand KG, et al. A superficial femoral artery aneurysm in a patient with Marfan’s syndrome. Eur J Vasc Endovascular Surg. 1998;15:459–460.
  • Safioleas MC, Kakisis D, Evangelidakis EL, et al. Thromboendarterectomy of the right common iliac artery in a patient with Marfan’s syndrome and restoration with a new technique. Int Angiology. 2001;20:241-243.
  • Ito M, Kuroda S, Nakayama N, et al. Extracranial internal carotid artery aneurysm associated with marfan syndrome: case report. Neurol Surg. 2007;35;793-797.
  • González JMD, García BÁ, Lebrun JM, et al. Combined surgery for the treatment of bilateral subclavian artery aneurysm in Marfan syndrome. J Vasc Surg. 2007;45(1):180–182.
  • Awais M, Williams DM, Deeb GM, et al. Aneurysms of medium-sized arteries in Marfan syndrome. Ann Vasc Surg. 2013;27:1188.e5–1188.e7.
  • Patra S, Singh AP, Srinivas BC. Marfan syndrome with spontaneous rupture of aneurysm of common iliac artery. Indian Pediatr. 2013;50:507-508.
  • Gaertner S, Alembik Y, Cordeanu EM, et al. Should we systematically screen for peripheral arterial aneurysms in all patients with Marfan syndrome? Int J Cardiol. 2014;172:e94-e95.
  • Speciali JG, Lison MP, Junqueira GL. Aneurisma intracraniano na síndrome de Marfan: a case report. Arq Neuropsiquiatr. 2013;29(4):453–457.
  • Jourdan C, Artru F, Convert J, et al. Intracranial aneurysm and dysplasia of elastic tissue: pre- and postoperative problems. Agressologie. 1990;31(6):405–408.
  • Stehbens WE, Delahunt B, Hilless AD. Early berry aneurysm formation in marfan’s syndrome. Surg Neurol. 1989;31(3):200–202.
  • Schievink WI, Parisi JE, Piepgras DG, et al. Intracranial aneurysms in Marfan’s syndrome: an autopsy study. Neurosurgery. 1997;41(4):866–871.
  • Kubo Y, Ogasawara K, Kurose A, et al. Ruptured cerebral fusiform aneurysm with mucopolysaccharide deposits in the tunica media in a patient with Marfan syndrome. J Neurosurg. 2008;110(3):518–520.
  • Finney HL, Roberts TS, Anderson RE. Giant intracranial aneurysm associated with Marfan’s syndrome. J Neurosurg. 2009;45(3):342–347.
  • Matsuda M, Matsuda I, Handa H, et al. Intracavernous giant aneurysm associated with Marfan’s syndrome. Surg Neurol. 1979;12:119-121.
  • Ohtsuki H, Sugiura M, Iwaki K, et al. A case of Marfan’s syndrome with a ruptured distal middle cerebral aneurysm. Neurol Surg. 1984;12:983-985.
  • Resende LA, Asseis EA, Costa LS, et al. Síndrome de marfan e aneurismas intracranianos gigantes: relato de um caso. Arq Neuropsiquiatr. 1984;42:294–297.
  • Narycheva IA, Romkin MA, Sokolina NA, et al. [Neurologic manifestations of Ehlers-Danlos syndrome] Nevrologicheskie proiavleniia sindroma Elersa-Danlosa. ZhNevropatolPsikhiatrIm SSKorsakova. 1989;89:48-53. (Ed.^(Eds).
  • Higashida RT, Halbach VV, Hieshima GB, et al. Cavernous carotid artery aneurysm associated with Marfan’s syndrome: treatment by balloon embolization therapy. Neurosurgery. 1988;22(2):297–300.
  • Hainsworth PJ, Mendelow AD. Giant intracranial aneurysm associated with Marfan’s syndrome: a case report. J Neurol Neurosurg Psychiatry. 1991;54:471–472. (Ed.^(Eds).
  • Rose BS, Pretorius DL. Dissecting basilar artery aneurysm in Marfan syndrome: case report. Am J Neuroradiol. 1991;12:503-504.
  • Van Den Berg JSP, Limburg M, Hennekam RCM. Is Marfan syndrome associated with symptomatic intracranial aneurysms? Stroke. 1996;27(1):27:10–12.
  • Conway JE, Hutchins GM, Tamargo RJ. Marfan syndrome is not associated with intracranial aneurysms. Stroke. 1999;30(8):1632–1636.
  • Wityk RJ, Zanferrari C, Oppenheimer S. Neurovascular complications of Marfan Syndrome. Stroke. 2002;33:680–684.
  • Kim ST, Brinjikji W, Kallmes DF. Prevalence of intracranial aneurysms in patients with connective tissue diseases: A retrospective study. Am J Neuroradiol. 2016;37(8):1422–1426.
  • Debette S, Goeggel Simonetti B, Schilling S, et al. Familial occurrence and heritable connective tissue disorders in cervical artery dissection. Neurology. 2014;83(22):2023–2031.
  • Kim ST, Brinjikji W, Lehman VT, et al. Association between carotid artery tortuosity and carotid dissection: a case-control study. J Neurosurg Sci. 2018;62(4):413–417.
  • Brandt T, Orberk E, Weber R, et al. Pathogenesis of cervical artery dissections: association with connective tissue abnormalities. Neurology. 2001;57(1):24–30.
  • Alurkar A, Karanam LS, Oak S, et al. Carotid dissection in Marfan’s syndrome. Neurol India. 2013;61(2):206–207.
  • Zielinski T, Wolkanin-Bartnik J, Janaszek-Sitkowska H, et al. Persistent dissection of carotid artery in patients operated on for type A acute aortic dissection–carotid ultrasound follow-up. Int J Cardiol. 1999;70(2):133–139.
  • Giossi A, Ritelli M, Costa P, et al. Connective tissue anomalies in patients with spontaneous cervical artery dissection. Neurology. 2014;83(22):2032–2037.
  • Dittrich R, Heidbreder A, Rohsbach D, et al. Connective tissue and vascular phenotype in patients with cervical artery dissection. Neurology. 2007;68(24):2120–2124.
  • Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;117(21):2802–2813.
  • Grotemeyer D, Duran M, Park EJ, et al. Visceral artery aneurysms - follow-up of 23 patients with 31 aneurysms after surgical or interventional therapy. Langenbecks Arch Surg. 2009;394(6):1093–1100.
  • Powell RO, Babu SB, Bommayya G. Left gastric artery aneurysm in Marfan syndrome: A unique case. BMJ Case Rep. 2015;29:1-3.
  • Hagerty T, Geraghty P, Braverman AC. Abdominal aortic aneurysm in Marfan Syndrome. Ann Vasc Surg. 2017;40:294.e1–294.e6.
  • Van Dijk N, Boer MC, Mulder BJM, et al. Is fatigue in Marfan syndrome related to orthostatic intolerance? Clin Auton Res. 2008;18(4):187–193.
  • Tanoue LT. Pulmonary involvement in collagen vascular disease: A review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, sjögren’s syndrome, and relapsing polychondritis. J Thorac Imaging. 1992;7:62.
  • Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–485.
  • Corsico AG, Grosso A, Tripon B, et al. Pulmonary involvement in patients with Marfan syndrome. Panminerva Med. 2014;56:177-182.
  • De Maio F, Fichera A, De Luna V, et al. Orthopaedic aspects of marfan syndrome: the experience of a referral center for diagnosis of rare diseases. Adv Orthop. 2016;2016:1–6. 8275391.
  • Mayer O, Campbell R, Cahill P, et al. Thoracic Insufficiency Syndrome. Curr Probl Pediatr Adolesc Health Care. 2016;46(3):72–97.
  • Pyeritz RE, Francke U. The second international symposium on the Marfan syndrome. Am J Med Genet A. 1993;47(1):1–160.
  • Qiao J, Xu L, Liu Z, et al. Surgical treatment of scoliosis in Marfan syndrome: outcomes and complications. Eur Spine J. 2016;25(10):3288–3293.
  • Fraser S, Child A, Hunt I. Pectus updates and special considerations in Marfan syndrome. Pediatr Rep. 2017;9(4):7277.
  • Kelly Jr RE Jr, Obermeyer RJ, Nuss D. Diminished pulmonary function in pectus excavatum: from denying the problem to finding the mechanism. Ann Cardiothorac Surg. 2016;5(5):466–475.
  • Kanagaratnam A, Phan S, Tchantchaleishvilli V, et al. Ravitch versus nuss procedure for pectus excavatum: systematic review and meta-analysis. Ann Cardiothorac Surg. 2016;5(5):409–421.
  • Mao YZ, Tang ST, Li S. Comparison of the nuss versus ravitch procedure for pectus excavatum repair: an updated meta-analysis. J Pediatr Surg. 2017;52(10):1545–1552.
  • Yoon WW, Sedra F, Shah S, et al. Improvement of pulmonary function in children with early-onset scoliosis using magnetic growth rods. Spine (Phila Pa 1976). 2014;39:1196–1202.
  • Nossov SB, Curatolo E, Campbell RM, et al. VEPTR: are we reducing respiratory assistance requirements? J Pediatr Orthop. 2019;39(1):28–32.
  • Gadepalli SK, Hirschl RB, Tsai WC, et al. Vertical expandable prosthetic titanium rib device insertion: does it improve pulmonary function? J Pediatr Surg. 2011;46(1):77–80.
  • Gawkrodger DJ. Marfan’s syndrome presenting as bilateral spontaneous pneumothorax. Postgrad Med J. 1981;57:240–241.
  • Hall JR, Pyeritz RE, Dudgeon DL, et al. Pneumothorax in the Marfan Syndrome: prevalence and therapy. Ann Thorac Surg. 1984;37:500–504.
  • Hao W, Fang Y, Lai H, et al. Marfan syndrome with pneumothorax: case report and review of literatures. J Thorac Dis. 2017;9(12):E1100–E1103.
  • Fortea-Sanchis C, Ángel Yepes V, Priego Jiménez P, et al. Marfan Syndrome and pneumothorax. Cirugía Española (English Edition). 2015;93(8):e87–e88.
  • Viveiro C, Rocha P, Carvalho C, et al. Spontaneous pneumothorax as manifestation of Marfan syndrome. BMJ Case Rep. 2013;2013:bcr2013201697-bcr2013201697.
  • Dugan KC, Laxmanan B, Murgu S, et al. Management of persistent air leaks. Chest. 2017;152(2):417–423.
  • Pelizzo G, Arbustini E, Pasqua N, et al. Thoracoscopic treatment of pneumothorax in marfan syndrome: hemostatic patch to support lung resection recovery. Case Rep Surg. 2018;7597215:5.
  • Booms P, Cisler J, Mathews KR, et al. Novel exon skipping mutation in the fibrillin-1 gene: two ‘hot spots’ for the neonatal Marfan syndrome. Clin Genet. 1999;55(2):110–117.
  • Milewicz DM, Duvic M. Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. Am J Hum Genet. 1994;54(3):447–453.
  • Robbesom AA, Koenders MMJF, Smits NC, et al. Aberrant fibrillin-1 expression in early emphysematous human lung: A proposed predisposition for emphysema. Mod Pathol. 2008;21(3):297–307.
  • Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117–121.
  • König P, Boxer R, Morrison J, et al. Bronchial hyperreactivity in children with Marfan syndrome. Pediatr Pulmonol. 1991;11:29‐36.
  • Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, et al. Allergy: TGFβ receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med. 2013;5(195):195ra194.
  • Foster ME, Foster DR. Bronchiectasis and Marfan’s syndrome. Postgrad Med J. 1980;56:718–719.
  • Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan’s syndrome. Chest. 1977;72:672–673.
  • Chisholm JC, Cherniack NS, Carton RW. Results of pulmonary function testing in 5 persons with the Marfan syndrome. J Lab Clin Med. 1968;71:25–28.
  • Cistulli PA, Sullivan CE. Sleep disorders in Marfan’s syndrome. Lancet. 1991;337(8753):1359–1360.
  • Cistulli PA, Sullivan CE. Sleep-disordered breathing in Marian’s syndrome. Amer Rev Respir Dis. 2013;147(3):645–648.
  • Kohler M, Blair E, Risby P, et al. The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan’s syndrome. Thorax. 2009;64:162–166.
  • Rybczynski M, Koschyk D, Karmeier A, et al. Frequency of sleep apnea in adults with the marfan syndrome. Am J Cardiol. 2010;105(12):1836–1841.
  • Cistulli PA, Sullivan CE. Sleep apnea in Marfan’s syndrome: increased upper airway collapsibility during sleep. Chest. 1995;108:631-635.
  • Cistulli PA, Gotsopoulos H, Sullivan CE. Relationship between craniofacial abnormalities and sleep-disordered breathing in Marfan’s syndrome. Chest. 2001;120:1455–1460.
  • Muiño Mosquera L, Bauters F, Dhondt K. Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome. Mol Genet Genomics. 2019;7:e805.
  • Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2002;342(19):1378–1384.
  • O’Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the sleep heart health study. Am J Respir Crit Care Med. 2009;179:1159-1164.
  • Lee W, Nagubadi S, Kryger MH, et al. Epidemiology of obstructive sleep apnea: A population-based perspective. Expert Rev Respir Med. 2008;2(3):349–364.
  • Cano-Pumarega I, Barbé F, Esteban A, et al. Sleep apnea and hypertension: are there sex differences? The vitoria sleep cohort. Chest. 2017;152(4):742–750.
  • Bauters F, Rietzschel ER, Hertegonne KBC, et al. The link between obstructive sleep apnea and cardiovascular disease. Curr Atheroscler Rep. 2016;18(1):8.
  • Serizawa N, Yumino D, Takagi A, et al. Obstructive sleep apnea is associated with greater thoracic aortic size. J Am Coll Cardiol. 2008;52:885–886.
  • Meuleman C, Boccara F, Nguyen XL, et al. Is the aortic root dilated in obstructive sleep apnoea syndrome? Arch Cardiovasc Dis. 2008;101:391–397.
  • Cicek D, Lakadamyali H, Yaǧbasan BD, et al. Obstructive sleep apnoea and its association with left ventricular function and aortic root parameters in newly diagnosed, untreated patients: a prospective study. J Int Med Res. 2011;39(6):2228–2238.
  • Baguet J-P, Minville C, Tamisier R, et al. Increased aortic root size is associated with nocturnal hypoxia and diastolic blood pressure in obstructive sleep apnea. Sleep. 2011;34(11):1605–1607.
  • Kohler M, Pitcher A, Blair E, et al. The impact of obstructive sleep apnea on aortic disease in marfan’s syndrome. Respiration. 2013;86:39–44.
  • Chow K, Pyeritz RE, Litt HI. Abdominal visceral findings in patients with Marfan syndrome. Genet Med. 2007;9:208–212.
  • Merza AP, Raiser MW. Biliary tract manifestations of the Marfan syndrome. Am J Gastroenterol. 1987;82:779-782.
  • Stheneur C, Faivre L, Collod-Béroud G, et al. Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res. 2011;69(3):265–270.
  • Ayse Esin K, Bahar C, Fatih A, et al. Delayed presentation of morgagni hernia in a patient with Marfan syndrome. Pediatr Int. 2010;52:e17-e19.
  • Beck TF, Campeau PM, Jhangiani SN, et al. FBN1 contributing to familial congenital diaphragmatic hernia. Am J Med Genet A. 2015;167:831–836.
  • Broad JB, Wu Z, Clark TG, et al. Diverticulosis and nine connective tissue disorders: epidemiological support for an association. Connect Tissue Res. 2019;60(4):389–398.
  • Romere C, Duerrschmid C, Bournat J, et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 2016;165(3):566–579.
  • Duerrschmid C, He Y, Wang C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444–1453.
  • Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20(4):242–258.
  • Brownstein AJ, Bin Mahmood SU, Saeyeldin A, et al. Simple renal cysts and bovine aortic arch: markers for aortic disease. Open Heart. 2019;6(1):e000862.
  • Hibender S, Wanga S, van der Made I, et al. Renal cystic disease in the Fbn1 C1039G/+ Marfan mouse is associated with enhanced aortic aneurysm formation. Cardiovasc Pathol. 2019 [38(January–February)];38:1–6.
  • Bouleti C, Flamant M, Escoubet B, et al. Risk of ascending aortic aneurysm in patients with autosomal dominant polycystic kidney disease. Am J Cardiol. 2019;123(3):482–488.
  • Biermann CW, Gasser TC, Breuer C, et al. [Marfan syndrome and cystic kidneys of the adult type]. Helv Chirurgica Acta. 1992;59(3):513–515.
  • Hateboer N, Buchalter M, Davies SJ, et al. Co-occurrence of autosomal dominant polycystic kidney disease and Marfan syndrome in a kindred. Am J Kidney Dis. 2000;35(4):753–760.
  • Somlo S, Rutecki G, Giuffra LA, et al. A kindred exhibiting cosegregation of an overlap connective tissue disorder and the chromosome 16 linked form of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;4(6):1371–1378.
  • Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–337.
  • Al-Haggar M, Bakr A, Wahba Y, et al. A novel fibrillin-1 mutation in an egyptian marfan family: A proband showing nephrotic syndrome due to focal segmental glomerulosclerosis. Saudi J Kidney Dis Transpl. 2017;28(1):141–148.
  • Gupta A, Gaikwad J, Khaira A, et al. Marfan syndrome and focal segmental glomerulosclerosis: a novel association. Saudi J Kidney Dis Transpl. 2010;21:754–755..
  • Sbar GD, Venkataseshan VS, Huang Z, et al. Renal disease in marfan syndrome. Am J Nephrol. 1996;16:320–326.
  • Hartner A, Schaefer L, Porst M, et al. Role of fibrillin-1 in hypertensive and diabetic glomerular disease. Am J Physiol Renal Physiol. 2005;290(6):F1329–1336.
  • Baum MA, Harris HW, Burrows PE, et al. Renovascular hypertension in Marfan syndrome. Pediatr Nephrol. 1997;11(4):499–501.
  • Loughridge LW. Renal abnormalities in the marfan syndrome. QJM. 1959;28:531-544.
  • Schoeneman MJ, Plewinska M, Mucha M, et al. Marfan syndrome and medullary sponge kidney: case report and speculation on pathogenesis. Int J Pediatr Nephrol. 1984;5:103-104.
  • Civilibal M, Caliskan S, Numan F, et al. Renovascular hypertension in a child with Marfan syndrome. Anatol J Cardiol. 2010;10:E11-E11.
  • Curry RA, Gelson E, Swan L, et al. Marfan syndrome and pregnancy: maternal and neonatal outcomes. BJOG. 2014;121(5):610–617.
  • Liang ST. Marfan syndrome, recurrent preterm labour and grandmultiparity. Aust N Z J Obstet Gynaecol. 1985;25(4):288–289.
  • Anum EA, Hill LD, Pandya A, et al. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta. 2009;30(3):207–215.
  • Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):28–35.
  • Rossiter JP, Repke JT, Morales AJ, et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–1606.
  • Lipscomb KJ, Smith JC, Clarke B, et al. Outcome of pregnancy in women with Marfan’s syndrome. Br J Obstet Gynaecol. 1997;104(2):201–206.
  • Meijboom LJ, Drenthen W, Pieper PG, et al. Obstetric complications in Marfan syndrome. Int J Cardiol. 2006;110(1):53–59.
  • Chan SSC, Chan DKH, Pang SMW, et al. Urinary incontinence should be added to the manifestation in women with Marfan syndrome. Int Urogynecol J. 2010;21(5):583–587.
  • Child AH. Non-cardiac manifestations of Marfan syndrome. Ann Cardiothorac Surg. 2017;6:599–609.
  • Carley ME, Schaffer J. Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers-Danlos syndrome. Am J Obstet Gynecol. 2000;182(5):1021–1023.
  • Minassian VA, Yan X, Lichtenfeld MJ, et al. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J. 2012;23(8):1087–1093.
  • Harris SS, Link CL, Tennstedt SL, et al. Care seeking and treatment for urinary incontinence in a diverse population. J Urol. 2007;177(2):680–684.
  • Hannestad YS, Rortveit G, Hunskaar S. Help-seeking and associated factors in female urinary incontinence. the norwegian epincont study. epidemiology of incontinence in the county of Nord-Trøndelag. Scand J Prim Health Care. 2002;20:102–107.
  • Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123:141–148.
  • O’Halloran T, Bell RJ, Robinson PJ, et al. Urinary incontinence in young nulligravid women: A cross-sectional analysis. Ann Intern Med. 2012;157(2):87–93.
  • Jabs C, Child AH. Genitourinary tract in women with Marfan syndrome. In: Child AH, editor. Diagnosis and management of Marfan syndrome. London: Springer. 2016. p. 219–225.
  • Hentzen C, Turmel N, Chesnel C, et al. urinary disorders and Marfan syndrome: a series of 4 cases. Urol Int. 2018;101(3):369–371.
  • Epenetos AA, Collis CH. Seminoma in Marfan’s syndrome. Postgrad Med J. 1979;55(648):762–764.
  • Berkowitz GS, Lapinski RH, Dolgin SE, et al. Prevalence and natural history of cryptorchidism. Pediatrics. 1993;92(1):44–49.
  • Schneider MB, Dittmar S, Boxer RA. Anterior sacral meningocele presenting as a pelvic/abdominal mass in a patient with Marfan syndrome. J Adolesc Health. 1993;14(4):325–328.
  • Sahin N, Genc M, Kasap E, et al. Anterior sacral meningocele masquerading as an ovarian cyst: a rare clinical presentation associated with Marfan Syndrome. Clin Pract. 2015;5(2):752.
  • Burks TN, Cohn RD. Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle. 2011;1(1):19.
  • Cohn RD, Van Erp C, Habashi JP, et al. Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat Med. 2007;13(2):204–210.
  • Jones KB, Sponseller PD, Erkula G, et al. Symposium on the musculoskeletal aspects of marfan syndrome: meeting report and state of the science. J Orthop Res. 2007;25(3):413–422.
  • Haine E, Salles JP, Khau Van Kien P, et al. Muscle and bone impairment in children with Marfan syndrome: correlation with age and FBN1 genotype. J Bone Miner Res. 2015;30:1369–1376.
  • Delaney K, Kasprzycka P, Ciemerych MA, et al. The role of TGF-β1 during skeletal muscle regeneration. Cell Biol Int. 2017;41(7):706–715.
  • Kim J, Lee J. Role of transforming growth factor-β in muscle damage and regeneration: focused on eccentric muscle contraction. J Exerc Rehabil. 2017;13(6):621–626.
  • Giske L, Stanghelle JK, Rand-Hendrikssen S, et al. Pulmonary function, working capacity and strength in young adults with Marfan syndrome. J Rehabil Med. 2003;35:221–228.
  • Percheron G, Fayet G, Ningler T, et al. Muscle strength and body composition in adult women with Marfan syndrome. Rheumatology. 2007;46(6):957–962.
  • Behan WMH, Longman C, Petty RKH, et al. Muscle fibrillin deficiency in Marfan’s syndrome myopathy. J Neurol Neurosurg Psychiatry. 2003;74(5):633–638.
  • Krueger C, Hoffmann FM. Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1. PLoS ONE. 2010;5:e15511.
  • Kohlmeier L, Gasner C, Marcus R. Bone mineral status of women with Marfan syndrome. Am J Med. 1993;95:568–572.
  • Kohlmeier L, Gasner C, Bachrach LK, et al. The bone mineral status of patients with marfan syndrome. J Bone Miner Res. 1995;10:1550-1555.
  • Le Parc JM, Plantin P, Jondeau G, et al. Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporos Int. 1999;10(6):475–479.
  • Carter N, Duncan E, Wordsworth P. Bone mineral density in adults with Marfan syndrome. Rheumatology (Oxford). 2000;39:307–309.
  • Moura B, Tubach F, Sulpice M, et al. Bone mineral density in Marfan syndrome. A large case-control study. Joint Bone Spine. 2006;73:733–735.
  • Grover M, Brunetti-Pierri N, Belmont J, et al. Assessment of bone mineral status in children with Marfan syndrome. Am J Med Genet A. 2012;158A:2221–2224.
  • Trifirò G, Marelli S, Viecca M, et al. Areal bone mineral density in children and adolescents with Marfan syndrome: evidence of an evolving problem. Bone. 2015;73:176–180.
  • Gray JR, Bridges AB, Mole PA, et al. Osteoporosis and the Marfan syndrome. Postgrad Med J. 1993;69:373–375.
  • Tobias JH, Dalzell N, Child AH. Assessment of bone mineral density in women with marfan syndrome. Rheumatology. 1995;34(6):516–519.
  • Giampietro PF, Peterson M, Schneider R, et al. Assessment of bone mineral density in adults and children with Marfan syndrome. Osteoporos Int. 2003;14:559-563.
  • Smaldone S, Clayton NP, Del Solar M, et al. Fibrillin-1 regulates skeletal stem cell differentiation by modulating TGFβ activity within the marrow niche. J Bone Miner Res. 2016;31(1):86–97.
  • Nistala H, Lee-Arteaga S, Smaldone S, et al. Fibrillin-1 and −2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol. 2010;190:1107–1121.
  • Rifkin DB, Todorovic V. Bone matrix to growth factors: location, location, location. J Cell Biol. 2010;190(6):949–951.
  • Chen S, Grover M, Sibai T, et al. Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol Genet Metab. 2015;115(1):53–60.
  • Nistala H, Lee-Arteaga S, Carta L, et al. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet. 2010;19(24):4790–4798.
  • Dolci C, Pucciarelli V, Gibelli DM, et al. The face in marfan syndrome: a 3D quantitative approach for a better definition of dysmorphic features. Clin Anat. 2018;31(3):380–386.
  • Ting BL, Mathur D, Loeys BL, et al. The diagnostic value of the facial features of Marfan syndrome. J Children’s Orthopaedics. 2010;4:545–551.
  • Westling L, Mohlin B, Bresin A. Craniofacial manifestations in the Marfan syndrome: palatal dimensions and a comparative cephalometric analysis. J Craniofac Genet Dev Biol. 1998;18:211–218.
  • Cistulli PA, Sullivan CE. Influence of maxillary morphology on nasal airway resistance in Marfan’s syndrome. Acta Otolaryngol. 2000;120:410-413.
  • Rybczynski M, Bernhardt AMJ, Rehder U, et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A. 2008;146A(24):3157–3166.
  • De Coster P, Pauw GD, Martens L, et al. Craniofacial structure in Marfan syndrome: a cephalometric study. Am J Med Genet A. 2004;131(3):240–248.
  • Child AH. Non-cardiac manifestations of Marfan syndrome. Ann Cardiothorac Surg. 2017;6(6):599–609.
  • Garreau de Loubresse C, Mullins MM, Moura B, et al. Spinal and pelvic parameters in Marfan’s syndrome and their relevance to surgical planning. J Bone Joint Surg Br. 2006;88(4):515–519.
  • Grahame R, Pyeritz RE. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br J Rheumatol. 1995;34:126–131.
  • Ledoux M, Beauchet A, Fermanian C, et al. A case-control study of cutaneous signs in adult patients with Marfan disease: diagnostic value of striae. J Am Acad Dermatol. 2011;64:290–295.
  • Ziv R, Schewach-Millet M, Trau H, et al. Alopecia universalis in a patient with Marfan’s syndrome. Israel J Med Sci. 1990;26:705–707.
  • Herman KL, Salman K, Rose LI. White forelock in Marfan’s syndrome: an unusual association, with review of the literature. Cutis. 1991;48:82-84.
  • Harper JI, Sidwell RU. Vermiculate atrophoderma in a boy with Marfan syndrome. Br J Dermatol. 1999;141(4):750–752.
  • Nallegowda M, Yadav SL, Singh U, et al. An unusual nail presentation in Marfan’s syndrome. J Dermatol. 2002;29(3):164–167.
  • Graul-Neumann LM, Kienitz T, Robinson PN, et al. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3ʹ terminus of the FBN1-gene. Am J Med Genet A. 2010;152A(11):2749–2755.
  • De Coster PJA, Martens LCM, De Paepe A. Oral manifestations of patients with Marfan syndrome: A case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(5):564–572.
  • Rahman A, Danne N, Geurtsen W, et al. Kariesprävalenz bei kindern mit Marfan-Syndrom. Oralprophylaxe Und Kinderzahn Hkd. 2014;36:3.
  • Staufenbiel I, Hauschild C, Kahl-Nieke B, et al. Periodontal conditions in patients with Marfan syndrome - a multicenter case control study. BMC Oral Health. 2013;13:1-5.
  • Bauss O, Neter D, Rahman A. Prevalence of pulp calcifications in patients with Marfan syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2008;106(6):e56–e61.
  • Bauss O, Sadat-Khonsari R, Fenske C, et al. Temporomandibular joint dysfunction in Marfan syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:592–598.
  • Martin VT, Neilson D. Joint hypermobility and headache: the glue that binds the two together - part 2. Headache. 2014;54(8):1403–1411.
  • Koppen H, Vis JC, Gooiker DJ, et al. Aortic root pathology in Marfan syndrome increases the risk of migraine with aura. Cephalalgia. 2012;32(6):467–472.
  • Tronvik E, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. J Am Med Assoc. 2003;289(1):65–69.
  • Davenport RJ, Chataway SJS, Warlow CP. Spontaneous intracranial hypotension from a CSF leak in a patient with Marfan’s syndrome. J Neurol Neurosurg Psychiatry. 1995;59(5):516–519.
  • Schievink WI, Gordon OK, Tourje J, et al. Connective tissue disorders with spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension: a prospective study. Neurosurgery. 2004;54(1):65–71.
  • Milledge JT, Ades LC, Cooper MG, et al. Severe spontaneous intracranial hypotension and Marfan syndrome in an adolescent. J Paediatr Child Health. 2005;41:68–71.
  • Puget S, Kondageski C, Wray A, et al. Chiari-like tonsillar herniation associated with intracranial hypotension in Marfan syndrome. J Neurosurg Pediatr. 2008;106(1 Suppl):48–52.
  • Albayram S, Baş A, Ozer H, et al. Spontaneous intracranial hypotension syndrome in a patient with Marfan syndrome and autosomal dominant polycystic kidney disease. Headache. 2008;48(4):632–636.
  • Cheuret E, Edouard T, Mejdoubi M, et al. Intracranial hypotension in a girl with Marfan syndrome: case report and review of the literature. Child’s Nerv Syst. 2008;24:509–513.
  • Bassani L, Graffeo C, Behrooz N, et al. Noninvasive diagnosis and management of spontaneous intracranial hypotension in patients with marfan syndrome: case report and review of the literature. Surg Neurol Int. 2014;5(1):8.
  • Uysal S, Albayram S, Ercan ET. Spontaneous intracranial hypotension: A case report. J Child Neurol. 2008;23:1312–1315.
  • Schievink WI, Maya MM, Louy C, et al. Diagnostic criteria for spontaneous spinal CFS leaks and intracranial hypotension. Am J Neuroradiol. 2008;29(5):853–856.
  • Low PA, Tomalia VA. Orthostatic hypotension: mechanisms, causes, management. J Clin Neurol. 2015;11(3):220–226.
  • De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet A. 1996;62(4):417–426.
  • Hofman KJ, Bernhardt BA, Pyeritz RE. Marfan syndrome: neuropsychological aspects. Am J Med Genet A. 1988;31:331–338.
  • Handisides JC, Hollenbeck-Pringle D, Uzark K, et al. Health-related quality of life in children and young adults with Marfan Syndrome. J Paediatr. 2019;204:250–255.e251.
  • Lannoo E, Paepe AD, Leroy B, et al. Neuropsychological aspects of Marfan syndrome. Clin Genet. 2008;65–9(2):65–69.
  • Rand-Hendriksen S, Sørensen I, Holmström H, et al. Fatigue, cognitive functioning and psychological distress in Marfan syndrome, a pilot study. Psychol Health Med. 2007;12:305–313.
  • Leone JC, Swigar ME. Marfan’s Syndrome and neuropsychiatric symptoms: case report and literature review. Compr Psychiatry. 1986;27(3):247–250.
  • Romano J. Marfan’s Syndrome and Schizophrenia: a case report. Arch Gen Psychiatry. 2011;44(2):190–192.
  • Gritti A, Pisano S, Catone G, et al. Psychiatric and neuropsychological issues in Marfan syndrome: A critical review of the literature. Int J Psychiatry Med. 2015;50:347–360. (Ed.^(Eds).
  • Sirota P, Frydman M, Sirota L. Schizophrenia and Marfan syndrome. Br J Psychiatry. 1990;157:433–436.
  • Kalsi G, Mankoo BS, Brynjolfsson J, et al. The Marfan syndrome gene locus as a favoured locus for susceptibility to schizophrenia. Psychiatr Genet. 1994;4(4):219–227.
  • Mercuro G, Carpzniello B, Ruscazio M, et al. Association between psychiatric disorders and Marfan’s syndrome in a large sardinian family with a high prevalence of cardiac abnormalities. Clin Cardiol. 1997;20(3):243–245.
  • Stramesi F, Politi P, Fusar-Poli P. Marfan syndrome and liability to psychosis. Med Hypotheses. 2007;68(5):1173–1174.
  • Rao NP, Loganathan S, Prakash O, et al. Use of electroconvulsive therapy for schizophrenia with comorbid marfan syndrome. J Ect. 2009;25:276–277.
  • Lemberg M, Thompson AW. Marfan syndrome and schizophrenia: a case report and literature review. Gen Hosp Psychiatry. 2010;32:228.e9–228.e10.
  • Van Den Bossche MJA, Van Wallendael KLP, Strazisar M, et al. Co-occurrence of Marfan syndrome and schizophrenia: what can be learned? Eur J Med Genet. 2012;55(4):252–255.
  • Sahadevan S, Nakulan A, John S, et al. Gender and psychiatric manifestations in Marfan syndrome-is there a link. Aust N Z J Psychiatry. 2014;48:588. (Ed.^(Eds).
  • Van Tongerloo A, De Paepe A. Psychosocial adaptation in adolescents and young adults with Marfan syndrome: an exploratory study. J Med Genet. 1998;35:405–409.
  • Wanson L, Godfroid IO. Psychiatric symptoms and Marfan: part of the syndrome or incidental to it? World J Biol Psychiatry. 2002;3:229–230.
  • Peters KF, Kong F, Hanslo M, et al. Living with Marfan syndrome III. quality of life and reproductive planning. Clin Genet. 2002;62(2):110–120.
  • Jha VN, Kumar M, Tarwani J. Co-occurrence of Marfan syndrome and bipolar disorder: A fifteen year follow up. Asian J Psychiatr. 2016;24:91–92.
  • Benke K, Ágg B, Pólos M, et al. The effects of acute and elective cardiac surgery on the anxiety traits of patients with Marfan syndrome. BMC Psychiatry. 2017;17(1):253–260.
  • Benninghoven D, Hamann D, Von Kodolitsch Y, et al. Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study. Orphanet J Rare Dis. 2017;12:127.
  • Goldfinger JZ, Preiss LR, Hendershot TP, et al. Marfan Syndrome and quality of life in the genTAC registry. J Am Coll Cardiol. 2017;69(23):2821–2830.
  • Bathen T, Velvin G, Rand-Hendriksen S, et al. Fatigue in adults with Marfan syndrome, occurrence and associations to pain and other factors. Am J Med Genet A. 2014;164:1931–1939.
  • Velvin G, Bathen T, Rand-Hendriksen S, et al. Work participation in adults with Marfan syndrome: demographic characteristics, MFS related health symptoms, chronic pain, and fatigue. Am J Med Genet A. 2015;167A(12):3082–3090.
  • Velvin G, Bathen T, Rand-Hendriksen S, et al. Satisfaction with life in adults with Marfan syndrome (MFS): associations with health-related consequences of MFS, pain, fatigue, and demographic factors. Qual Life Res. 2016;25(7):1779–1790.
  • Rao SS, Venuti KD, Dietz H, et al. Quantifying health status and function in Marfan Syndrome. J Surg Orthop Adv. 2016;25:34–40.
  • Velvin G, Bathen T, Rand-Hendriksen S, et al. Systematic review of chronic pain in persons with Marfan syndrome. Clin Genet. 2016;89(6):647–658.
  • Nelson AM, Walega DR, McCarthy RJ. The incidence and severity of physical pain symptoms in marfan syndrome a survey of 993 patients. Clin J Pain. 2015;31:1080–1086. (Ed.^(Eds).
  • Speed TJ, Mathur VA, Hand M, et al. Characterization of pain, disability, and psychological burden in Marfan syndrome. Am J Med Genet A. 2017;173(2):315–323.
  • Mamiya S, Endo Y, Miura AB, et al. Disseminated intravascular coagulation accompanying thoracic and abdominal aortic aneurysm; Report of three cases. Jpn J Med. 2011;27(1):91–95.
  • Alarcón-Segovia D, Javier Fierro F, de Jésus Villalobos J, et al. Bilateral renal vein thrombosis and nephrotic syndrome in a patient with the Marfan syndrome. Dis Chest. 2007;54(2):153–156.
  • Humphries JE, Stouffer GA, Kelly TE, et al. Hypercoagulability in a patient with Marfan syndrome. J Med Genet. 1991;28(5):349–351.
  • Touat Z, Lepage L, Ollivier V, et al. Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm. Arterioscler Thromb Vasc Biol. 2008;28:940–946.
  • Kornhuber K, Seidel H, Pujol C, et al. Hemostatic abnormalities in adult patients with Marfan syndrome. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S209–S220.
  • Ihara A, Kawamoto T, Matsumoto K, et al. Relationship between hemostatic markers and circulating biochemical markers of collagen metabolism in patients with aortic aneurysm. Pathophysiol Haemost Thromb. 2003;33(4):221–224.
  • Nomura F, Ihara A, Yoshitatsu M, et al. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg. 2003;23(6):1034–1039.
  • Sidloff DA, Stather PW, Choke E, et al. A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg. 2014;59(2):528–535.e524.
  • Yuan S-M, Shi Y-H, Wang -J-J, et al. Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders. Braz J Cardiovasc Surg. 2011;26:573-581.
  • Bridges AB, Gray JR, McLaren M, et al. Endothelial cell and platelet function in Marfan’s Syndrome. Endothelium. 1993;1(3):203–206.
  • Hirata K, Triposkiadis F, Sparks E, et al. The marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol. 1991;18(1):57–63.
  • Bogren HG, Mohiaddin RH, Yang GZ, et al. Magnetic resonance velocity vector mapping of blood flow in thoracic aortic aneurysms and grafts. J Thorac Cardiovasc Surg. 1995;110(3):704–714.
  • Geiger J, Hirtler D, Gottfried K, et al. Longitudinal evaluation of aortic hemodynamics in Marfan Syndrome: new Insights from a 4D flow cardiovascular magnetic resonance multi-year follow-up study. J Cardiovasc Magn Reson. 2017;19(1):33.
  • Geiger J, Markl M, Herzer L, et al. Aortic flow patterns in patients with Marfan syndrome assessed by flow-sensitive four-dimensional MRI. J Magn Reson Imaging. 2012;35:594–600.
  • Wang HH, Chiu HH, Tseng WYI, et al. Does altered aortic flow in marfan syndrome relate to aortic root dilatation? J Magn Reson Imaging. 2016;44(2):500–508.
  • Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;1729–37(8):1729–1737.
  • Gogia S, Neelamegham S. Role of fluid shear stress in regulating VWF structure, function and related blood disorders. Biorheology. 2015;52(5–6):319–335.
  • Horiuchi H. [A hemostatic disorder caused by high shear stress: acquired von Willebrand syndrome]. [Rinsho Ketsueki] Jpn J Clin Hematol. 2018;59:2233–2237.
  • Petricevic M, Knezevic J, Samoukovic G, et al. Diagnosis and management of acquired von willebrand disease in heart disease: a review of the literature. Thorac Cardiovasc Surg. 2018. doi:https://doi.org/10.1055/s-0038-1673670.
  • Fressinaud E. Von-Willebrand-syndrome type 2; 2009.
  • Frank RD, Lanzmich R, Haager PK, et al. Severe aortic valve stenosis. Clin Appl Thromb Hemost. 2017;23:229–234.
  • Iijima M, Itoh N, Murase R, et al. A surgical case of aortic stenosis with recurrent gastrointestinal bleeding: heyde syndrome. Int J Surg Case Rep. 2018;53:281–284.
  • Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349(4):343–349.
  • Blackshear JL, McRee CW, Safford RE, et al. Von willebrand factor abnormalities and heyde syndrome in dysfunctional heart valve prostheses. JAMA Cardiol. 2016;1(2):198–204.
  • Anstey A, Mayne K, Winter M, et al. Platelet and coagulation studies in Ehlers‐Danlos syndrome. Br J Dermatol. 1991;125(2):155–163.
  • Artoni A, Bassotti A, Abbattista M, et al. Hemostatic abnormalities in patients with Ehlers–danlos syndrome. J Thromb Haemost. 2018;16(12):2425–2431.
  • Busch A, Hoffjan S, Bergmann F, et al. Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low Vitamin D serum concentration. Orphanet J Rare Dis. 2016;11:111.
  • Scheibenberger D, Frings A, Steinberg J, et al. Ocular manifestation in Marfan syndrome: corneal biomechanical properties relate to increased systemic score points. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:1159–1163.
  • Pyeritz RE. Marfan syndrome: improved clinical history results in expanded natural history. Genet Med. 2019;21(8):1683–1690.
  • von Kodolitsch Y, Bernhardt AM, Kölbel T, et al. Maximizing therapeutic success: the key concepts of individualized medical strategy (IMS). Cogent Med. 2015;2(1):1109742.
  • Héon-Klin V. European Reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12(1):137.
  • Mercieca-Bebber R, King MT, Calvert MJ, et al. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;9:53–367.
  • von Kodolitsch Y, Rybczynski M, Vogler M, et al. The role of the multidisciplinary health care team in the management of patients with Marfan syndrome. J Multidiscip Healthc. 2016;9:587–614.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.